Shares of Biophytis S.A. BPTS exhibited notable growth during pre-market trading following the release of its FY23 results.
Biophytis reported a reduction in its FY23 loss to €0.03 per share, down from €0.14 per share in the previous year.
The surge in Biophytis shares amounted to an impressive 55.2%, reaching $0.4920 in pre-market transactions.
Discover the movements of other stocks in the pre-market session below.
Movers and Shakers
- MyMD Pharmaceuticals, Inc. MYMD shares surged by 40% to $3.64 in pre-market trading, following a 22% increase on Monday.
- MediaCo Holding Inc. MDIA depicted a rise of 20.2% to $3.63 during pre-market activity after a 22% dip on the preceding day. Recent SEC filings revealed a significant stake by Standard General L.P. in the company.
- Destiny Tech100 Inc. DXYZ experienced an increase of 18.5% to $118.33 in pre-market trading subsequent to a substantial 68% surge the day before.
- Addex Therapeutics Ltd ADXN saw a gain of 17.2% to $25.60 in pre-market trading following a rise of around 21% on Monday. Collaborating with funds linked to Perceptive Advisors, the company announced the launch of Neurosterix last week.
- Anghami Inc. ANGH observed an uptick of 16.1% to $1.30 during pre-market trading, rebounding from a 3% decline on Monday.
- Brainstorm Cell Therapeutics Inc. BCLI climbed by 15% to $0.8395 in pre-market trading, following an approximate 12% increase on Monday. The company recently released its FY23 financial results.
- Soligenix, Inc. SNGX recorded a gain of 12.5% to $0.54 in pre-market trading, building on a 3% increase on Monday.
- TuanChe Limited TC surged by 10.8% to $2.16 during pre-market trading.
- Halozyme Therapeutics, Inc. HALO advanced by 10.7% to $2.16 in pre-market trading, rebounding from a 3% decrease the day before.
Market Corrections
- Vincerx Pharma, Inc. VINC encountered a decline of 52.1% to $2.29 in pre-market trading subsequent to the company’s presentation of preliminary Phase 1 data for VIP236 and updates on pipeline progress at the AACR Annual Meeting 2024.
- Focus Universal Inc. FCUV plummeted by 30.8% to $0.2424 in pre-market trading. The company announced Warren Wang as Chief Strategy Officer on Monday.
- UTime Limited WTO declined by 26.1% to $0.2216 in pre-market trading. UTime shares surged by 62% the previous day following the completion of a private placement.
- BioSig Technologies, Inc. BSGM fell by 22.8% to $0.9570 in pre-market trading after a significant 96% leap on Monday.
- Guardion Health Sciences, Inc. GHSI shares declined by 20.8% to $7.05 in pre-market trading.
- Maxeon Solar Technologies, Ltd. MAXN dropped by 16.8% to $2.27 in pre-market trading. Maxeon Solar anticipated fourth-quarter revenues of $229 million, slightly lower than market estimates of $235.959 million.
- Hanryu Holdings, Inc. HRYU shares fell by 15.8% to $0.24 in pre-market trading, retracting from a 31% surge on Monday.
- VBI Vaccines Inc. VBIV experienced a decline of 12.4% to $0.8037 in pre-market trading after a 30% increase on Monday.
- Eco Wave Power Global AB WAVE shares dipped by 11.2% to $3.73 in pre-market trading. The decline followed a 219% surge on Monday triggered by the company’s selection by an international energy firm to conduct wave energy feasibility studies along the U.S. coastline.
- DigiAsia Corp. FAAS fell by 9.9% to $7.00 in pre-market trading after surging over 20% on Monday.
Now Read This: Tune into Neogen, Maxeon Solar Technologies, and 3 Stocks to Watch Heading Into Tuesday
